August 28, 2025- Cleveland Clinic and Dyania Health announced a collaboration to integrate Dyania Health’s Synapsis™ AI platform across Cleveland Clinic’s clinical research enterprise. This follows successful pilot programs in cardiology and oncology, as well as a unique effort where the teams jointly validated the technology’s effectiveness in neurology during an intensive testing period.
Together, the organizations aim to accelerate clinical trial recruitment by using medically trained large language models (LLMs) to speed up and scale patient identification for research studies, providing more patients faster access to potentially beneficial therapies.
Clinical trial recruitment remains one of the most persistent barriers to scientific progress. Approximately 80% of clinical trials do not meet enrollment timelines and 50% of trial sites fail to enroll any patients. By using artificial intelligence to automate chart review and rapidly identify eligible participants, Cleveland Clinic and Dyania Health are addressing these traditional enrollment bottlenecks and expanding patient access to potentially life-saving therapies.